Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Meeting highlights from the Paediatric Committee: 17 - 19 September 2008 28 september 2008Press releaseHumanPaediatrics UCB Pharma withdraws its marketing authorisation application for Lacosamide Pain UCB Pharma 26 september 2008Press release European Medicines Agency makes first recommendation for use of a medicine in children based on PIP data 25 september 2008Press releaseMedicinesPaediatrics Meeting highlights from the Committee for Medicinal Products for Human Use,22-25 September 2008 25 september 2008Press releaseHuman Takeda withdraws its marketing authorisation application for Ramelteon 25 september 2008Press release European Medicines Agency recommends update of product information of Tysabri and risk of progressive multifocal leukoencephalopathy (PML) 25 september 2008Press releaseMedicines Committee for medicinal products for veterinary use: Meeting of 16-18 September 2008 19 september 2008Press releaseVeterinary Pfizer withdraws its marketing authorisation application for Exulett (dalbavancin) 10 september 2008Press release EMEA releases guidelines on development of medicines for Alzheimer's disease and Parkinson's disease 4 september 2008Press releaseRegulatory and procedural guidance Meeting highlights from the Paediatric Committee: 29 - 31 July 2008 4 september 2008Press releaseHumanPaediatrics 1 … 306 307 308 309 310 Page 310 of 380 311 312 313 314 … 380
Meeting highlights from the Paediatric Committee: 17 - 19 September 2008 28 september 2008Press releaseHumanPaediatrics
UCB Pharma withdraws its marketing authorisation application for Lacosamide Pain UCB Pharma 26 september 2008Press release
European Medicines Agency makes first recommendation for use of a medicine in children based on PIP data 25 september 2008Press releaseMedicinesPaediatrics
Meeting highlights from the Committee for Medicinal Products for Human Use,22-25 September 2008 25 september 2008Press releaseHuman
Takeda withdraws its marketing authorisation application for Ramelteon 25 september 2008Press release
European Medicines Agency recommends update of product information of Tysabri and risk of progressive multifocal leukoencephalopathy (PML) 25 september 2008Press releaseMedicines
Committee for medicinal products for veterinary use: Meeting of 16-18 September 2008 19 september 2008Press releaseVeterinary
Pfizer withdraws its marketing authorisation application for Exulett (dalbavancin) 10 september 2008Press release
EMEA releases guidelines on development of medicines for Alzheimer's disease and Parkinson's disease 4 september 2008Press releaseRegulatory and procedural guidance
Meeting highlights from the Paediatric Committee: 29 - 31 July 2008 4 september 2008Press releaseHumanPaediatrics